The genetic and molecular basis of Fanconi anemia

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 668, Issue 1-2, 2009, Pages 11-19

  de Winter, Johan P ^a   Joenje, Hans ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

DNA cross linking agents; DNA repair; Fanconi anemia; Genomic instability; Replication

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP B PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP I PROTEIN; FANCONI ANEMIA GROUP J PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA GROUP M PROTEIN; FANCONI ANEMIA GROUP N PROTEIN; FANCONI ANEMIA PROTEIN; HISTONE H2AX; RAD51 PROTEIN; UNCLASSIFIED DRUG; XRCC3 PROTEIN;

ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; COMPLEX FORMATION; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COMPLEMENTATION; GENETIC LINKAGE; HUMAN; MISSENSE MUTATION; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

CROSS-LINKING REAGENTS; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENETIC COMPLEMENTATION TEST; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

VERTEBRATA;

EID: 67650500593     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.11.004     Document Type: Article

References (98)

1. Fanconi G. Familiäre infantile perniziosartige anämie (pernizioses blutbild und konstitution). Jahrb. Kinderh. 117 (1927) 257-280
2. Schroeder T.M., Anschütz F., and Knopp A. Spontane chromosomenaberrationen bei familiärer panmyelopathie. Humangenetik 1 (1964) 194-196
3. Sasaki M. Is Fanconi's anaemia defective in a process essential for the repair of DNA cross links?. Nature 257 (1975) 501-503
4. Auerbach A.D., and Wolman S.R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261 (1976) 494-496
5. Strathdee C.A., Duncan A.M., and Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat. Genet. 1 (1992) 196-198
6. Joenje H., Lo Ten Foe J.R., Oostra A.B., van Berkel C.G., Rooimans M.A., Schroeder-Kurth T., Wegner R.D., Gille J.J., Buchwald M., and Arwert F. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 86 (1995) 2156-2160
7. Joenje H., Oostra A.B., Wijker M., di Summa F.M., van Berkel C.G., Rooimans M.A., Ebell W., van Weel M., Pronk J.C., Buchwald M., and Arwert F. Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet. 61 (1997) 940-944
8. Levitus M., Rooimans M.A., Steltenpool J., Cool N.F., Oostra A.B., Mathew C.G., Hoatlin M.E., Waisfisz Q., Arwert F., de Winter J.P., and Joenje H. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103 (2004) 2498-2503
9. Joenje H., Levitus M., Waisfisz Q., D'Andrea A., Garcia-Higuera I., Pearson T., van Berkel C.G.M., Rooimans M.A., Morgan N., Mathew C.G., and Arwert F. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am. J. Hum. Genet. 67 (2000) 759-762
10. Gross M., Hanenberg H., Lobitz S., Friedl R., Heterich S., Dietrich R., Gruhn B., Schindler D., and Hoehn H. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet. Genome Res. 98 (2002) 126-135
11. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356 (1992) 763-767
12. Lo Ten Foe J.R., Rooimans M.A., Bosnoyan-Collins L., Alon N., Wijker M., Parker L., Lightfoot J., Carreau M., Callen D.F., Savoia A., Cheng N.C., van Berkel C.G., Strunk M.H., Gille J.J., Pals G., Kruyt F.A., Pronk J.C., Arwert F., Buchwald M., and Joenje H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet. 14 (1996) 320-323
13. de Winter J.P., Waisfisz Q., Rooimans M.A., van Berkel C.G.M., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J.C., Arwert F., Hoehn H., Digweed M., Buchwald M., and Joenje H. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20 (1998) 281-283
14. de Winter J.P., Rooimans M.A., van der Weel L., van Berkel C.G.M., Alon N., Bosnoyan-Collins L., De Groot J., Zhi Y., Waisfisz Q., Pronk J.C., Arwert F., Mathew C.G., Scheper R.J., Hoatlin M.E., Buchwald M., and Joenje H. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24 (2000) 15-16
15. de Winter J.P., Léveillé F., van Berkel C.G.M., Rooimans M.A., van der Weel L., Steltenpool J., Demuth I., Morgan N.V., Alon N., Bosnoyan-Collins L., Lightfoot J., Komatsu K., Arwert F., Leegwater P.A., Waisfisz Q., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., and Joenje H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67 (2000) 1306-1308
16. Kupfer G.M., Näf D., Pulsipher M., and D'Andrea A.D. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat. Genet. 17 (1997) 487-490
17. Garcia-Higuera I., Kuang Y., Näf D., Wasik J., and D'Andrea A.D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19 (1999) 4866-4873
18. de Winter J.P., van der Weel L., Kruyt F.A.E., de Groot J., Zhi Y., Waisfisz Q., Arwert F., Scheper R.J., Hoatlin M.E., and Joenje H. The Fanconi anaemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9 (2000) 2665-2674
19. Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M., de Winter J., Joenje H., Gergely F., and Patel K.J. FANCE: the link between Fanconi anemia complex assembly and activity. EMBO J. 21 (2002) 3414-3423
20. Blom E., van der Vrugt H.J., de Vries Y., de Winter J.P., Arwert F., and Joenje H. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair 3 (2004) 77-84
21. The Fanconi anaemia/breast cancer consortium, Positional cloning of the Fanconi anaemia group A gene, Nat. Genet. 14 (1996) 324-328.
22. Whitney M., Thayer M., Reifsteck C., Olson S., Smith L., Jacobs P.M., Leach R., Naylor S., Joenje H., and Grompe M. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat. Genet. 11 (1995) 341-343
23. Hejna J.A., Timmers C.D., Reifsteck C., Bruun D.A., Lucas L.W., Jacobs P.M., Toth-Fejel S., Unsworth N., Clemens S.L., Garcia D.K., Naylor S.L., Thayer M.J., Olson S.B., Grompe M., and Moses R.E. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3. Am. J. Hum. Genet. 66 (2000) 1540-1551
24. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., D'Andrea A.D., Moses R., and Grompe M. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7 (2001) 241-248
25. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
26. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and Grompe A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and Rad51. Blood 100 (2002) 2414-2420
27. Vandenberg C.J., Gergely F., Ong C.Y., Pace P., Mallery D.L., Hiom K., and Patel K.J. BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12 (2003) 247-254
28. Bogliolo M., Lyakhovich A., Callen E., Castellà M., Cappelli E., Ramirez M.J., Creus A., Marcos R., Kalb R., Neveling K., Schindler D., and Surrallés J. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 26 (2007) 1340-1351
29. Ward I.M., and Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276 (2001) 47759-47762
30. Andreassen P.R., D'Andrea A.D., and Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18 (2004) 1958-1963
31. Ho G.P., Margossian S., Taniguchi T., and D'Andrea A.D. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell Biol. 26 (2006) 7005-7015
32. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., and D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
33. Godthelp B.C., Arwert F., Joenje H., and Zdzienicka M.Z. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 21 (2002) 5002-5005
34. Alter B.P., Rosenberg P.S., and Brody L.C. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J. Med. Genet. 44 (2007) 1-9
35. Sharan S.K., Morimatsu M., Albrecht U., Lim D.S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., and Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386 (1997) 804-810
36. Cheng N.C., van der Vrugt H.J., van der Valk M.A., Oostra A.B., Krimpenfort P., de Vries Y., Joenje H., Berns A., and Arwert F. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum. Mol. Genet. 9 (2000) 1805-1811
37. Wong J.C., Alon N., Mckerlie C., Huang J.R., Meyn M.S., and Buchwald M. Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum. Mol. Genet. 12 (2003) 2063-2076
38. Chen M., Tomkins D.J., Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos C.J., Freedman M.H., Cross J., Percy D.H., Dick J.E., Joyner A.L., and Buchwald M. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12 (1996) 448-451
39. Whitney M.A., Royle G., Low M.J., Kelly M.A., Axthelm M.K., Reifsteck C., Olson S., Braun R.E., Heinrich M.C., Rathbun R.K., Bagby G.C., and Grompe M. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 88 (1996) 49-58
40. Houghtaling S., Timmers C., Noll M., Finegold M.J., Jones S.N., Meyn M.S., and Grompe M. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17 (2003) 2021-2035
41. Yang Y., Kuang Y., Montes De Oca R., Hays T., Moreau L., Lu N., Seed B., and D'Andrea A.D. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 98 (2001) 3435-3440
42. Koomen M., Cheng N.C., van de Vrugt H.J., Godthelp B.C., van der Valk M.A., Oostra A.B., Zdzienicka M.Z., Joenje H., and Arwert F. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum. Mol. Genet. 11 (2002) 273-281
43. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., de Winter J.P., Ashworth A., Jones N.J., and Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 (2004) 1241-1248
44. Wang X., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell Biol. 24 (2004) 5850-5862
45. Kennedy R.D., Chen C.C., Stuckert P., Archila E.M., De la Vega M.A., Moreau L.A., Shimamura A., and D'Andrea A.D. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J. Clin. Invest. 117 (2007) 1440-1449
46. Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., and Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell Biol. 23 (2003) 3417-3426
47. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
48. Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C., Rooimans M.A., Bier P., Hoatlin M., Pals G., de Winter J.P., Wang W., and Joenje H. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36 (2004) 1219-1224
49. Meetei A.R., Medhurst A.L., Ling C., Sue Y., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., and Wang W. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 (2005) 958-963
50. Gari K., Décaillet C., Stasiak A.Z., Stasiak A., and Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell 29 (2008) 141-148
51. Gari K., Décaillet C., Delannoy M., and Wu L. Constantinou, Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 16107-16112
52. Mosedale G., Niedzwiedz W., Alpi A., Perrina F., Pereira-Leal J.B., Johnson M., Langevin F., Pace P., and Patel K.J. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12 (2005) 763-771
53. Kim J.M., Kee Y., Gurtan A., and D'Andrea A.D. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 111 (2008) 5215-5222
54. Xue Y., Li Y., Guo R., Ling C., and Wang W. FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet. 17 (2008) 1641-1652
55. Ciccia A., Ling C., Coulthard R., Yan Z., Xue Y., Meetei A.R., Laghmani E.H., Joenje H., McDonald N., de Winter J.P., Wang W., and West S.C. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25 (2007) 331-343
56. Ling C., Ishiai M., Ali A.M., Medhurst A.L., Neveling K., Kalb R., Yan Z., Xue Y., Oostra A.B., Auerbach A.D., Hoatlin M.E., Schindler D., Joenje H., de Winter J.P., Takata M., Meetei A.R., and Weidong W. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26 (2007) 2104-2114
57. Niedernhofer L.J., Lalai A.S., and Hoeijmakers J.H. Fanconi anemia (cross)linked to DNA repair. Cell 123 (2005) 1191-1198
58. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., Elghalbzouri-Maghrani E., Steltenpool J., Rooimans M.A., Pals G., Arwert F., Mathew C.G., Zdzienicka M.Z., Hiom K., de Winter J.P., and Joenje H. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37 (2005) 934-935
59. Levran O., Attwooll C., Henry R.T., Milton K.L., Neveling K., Rio P., Batish S.D., Kalb R., Velleuer E., Barral S., Ott J., Petrini J., Schindler D., Hanenberg H., and Auerbach A.D. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat. Genet. 37 (2005) 931-933
60. Litman R., Peng M., Jin Z., Zhang F., Powell S., Andreassen P.R., and Cantor S.B. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8 (2005) 255-265
61. Bridge W.L., Vandenberg C.J., Franklin R.J., and Hiom K. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet. 37 (2005) 953-957
62. Cantor S.B., Bell D.W., Ganesan S., Kass E.M., Drapkin R., Grossman S., Wahrer D.C., Sgroi D.C., Lane W.S., Haber D.A., and Livingston D.M. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105 (2001) 149-160
63. Cantor S., Drapkin R., Zhang F., Lin Y., Pamidi S., and Livingston D.M. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2357-2362
64. Gupta R., Sharma S., Sommers J.A., Kenny M.K., Cantor S.B., and Brosh Jr. R.M. FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein. Blood 110 (2007) 2390-2398
65. Peng M., Litman R., Xie J., Sharma S., Brosh Jr. R.M., and Cantor S.B. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. EMBO J. 26 (2007) 3238-3249
66. Kruisselbrink E., Guryev V., Brouwer K., Pontier D.B., Cuppen E., and Tijsterman M. Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ-defective C. elegans. Curr. Biol. 18 (2008) 900-905
67. Youds J.L., Barber L.J., Ward J.D., Collis S.J., O'Neil N.J., Boulton S.J., and Rose A.M. DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair. Mol. Cell. Biol. 28 (2008) 1470-1479
68. Wu Y., Shin-Ya K., and Brosh Jr. R.M. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol. Cell. Biol. 28 (2008) 4116-4128
69. Xia B., Sheng Q., Nakanishi K., Ohashi A., Wu J., Christ N., Liu X., Jasin M., Couch F.J., and Livingston D.M. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22 (2006) 719-729
70. Xia B., Dorsman J.C., Ameziane N., de Vries Y., Rooimans M.A., Sheng Q., Pals G., Errami A., Gluckman E., Llera J., Wang W., Livingston D.M., Joenje H., and de Winter J.P. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39 (2007) 159-161
71. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freud M., Wurm M., Batish S.D., Lach F.P., Yetgin S., Neitzel H., Ariffin H., Tischkowitz M., Mathew C.G., Auerbach A.D., and Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 39 (2007) 162-164
72. Sakai W., Swisher E.M., Karlan B.Y., Agarwal M.K., Higgins J., Friedman C., Villegas E., Jacquemont C., Farrugia D.J., Couch F.J., Urban N., and Taniguchi T. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451 (2008) 1116-1120
73. Dorsman J.C., Levitus M., Rockx D., Rooimans M.A., Oostra A.B., Haitjema A., Bakker S.T., Steltenpool J., Schuler D., Mohan S., Schindler D., Arwert F., Pals G., Mathew C.G., Waisfisz Q., de Winter J.P., and Joenje H. Identification of the Fanconi anemia complementation group I gene, FANCI. Cell. Oncol. 29 (2007) 211-218
74. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald III E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., and Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129 (2007) 289-301
75. Sims A.E., Spiteri E., Sims III R.J., Arita A.G., Lach F.P., Landers T., Wurm M., Freund M., Neveling K., Hanenberg H., Auerbach A.D., and Huang T.T. FANCI the second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14 (2007) 564-567
76. Ishiai M., Kitao H., Smogorzewska A., Tomida J., Kinomura A., Uchida E., Saberi A., Kinoshita E., Kinoshita-Kikuta E., Koike T., Tashiro S., Elledge S.J., and Takata M. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 15 (2008) 1138-1146
77. Levitus M., Joenje H., and de Winter J.P. The Fanconi anemia pathway of genomic maintenance. Cell. Oncol. 28 (2006) 3-29
78. Ameziane N., Errami A., Léveillé F., Fontaine C., Waterham Y., Spaendonk R.M.L., de Winter J.P., and Pals G. Joenje, genetic subtyping of Fanconi anemia by comprehensive mutation screening. Hum. Mutat. 29 (2008) 159-166
79. Waisfisz Q., de Winter J.P., Kruyt F.A., de Groot J., van der Weel L., Dijkmans L.M., Zhi Y., Arwert F., Scheper R.J., Youssoufian H., Hoatlin M.E., and Joenje H. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10320-10325
80. Garcia-Higuera I., Kuang Y., Denham J., and D'Andrea A.D. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 96 (2000) 3224-3230
81. Adachi D., Oda T., Yagasaki H., Nakasato K., Taniguchi T., D'Andrea A.D., Asano S., and Yamashita T. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Hum. Mol. Genet. 11 (2002) 3125-3134
82. Yamashita T., Kupfer G.M., Näf D., Suliman A., Joenje H., Asano S., and D'Andrea A.D. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13085-13090
83. Medhurst A.L., Laghmani E.H., Steltenpool J., Ferrer M., Fontaine C., de Groot J., Rooimans M.A., Scheper R.J., Meetei A.R., Wang W., Joenje H., and de Winter J.P. Evidence for subcomplexes in the Fanconi anemia pathway. Blood 108 (2006) 2072-2080
84. Gordon S.M., and Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 102 (2003) 136-141
85. Medhurst A.L., Huber P.A.J., Waisfisz Q., de Winter J.P., and Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10 (2001) 423-429
86. Taniguchi T., and D'Andrea A.D. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 100 (2002) 2457-2462
87. Léveillé F., Ferrer M., Medhurst A.L., Laghmani E.H., Rooimans M.A., Bier P., Steltenpool J., Titus T.A., Postlethwait J.H., Hoatlin M.E., Joenje H., and Winter J.P. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC. DNA Repair 5 (2006) 556-565
88. Léveillé F., Blom E., Medhurst A.L., Bier P., Laghmani E.H., Johnson M., Rooimans M.A., Sobeck A., Waisfisz Q., Arwert F., Patel K.J., Hoatlin M.E., Joenje H., and de Winter J.P. The Fanconi anemia gene product FANCF is a flexible adaptor protein. J. Biol. Chem. 279 (2004) 39421-39430
89. Alpi A., Langevin F., Mosedale G., Machida Y.J., Dutta A., and Patel K.J. UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol. Cell Biol. 27 (2007) 8421-8430
90. Qiao F., Moss A., and Kupfer G.M. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J. Biol. Chem. 26 (2001) 23391-23396
91. Machida Y.J., Machida Y., Chen Y., Gurtan A.M., Kupfer G.M., D'Andrea A.D., and Dutta A. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23 (2006) 589-596
92. Wang X.Z., Kennedy R.D., Ray K., Struckert P., Ellenberger T., and D'Andrea A.D. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell Biol. 27 (2007) 3098-3108
93. Nijman S.M., Huang T.T., Dirac A.M., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., and Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17 (2005) 331-339
94. Oestergaard V.H., Langevin F., Kuiken H.J., Pace P., Niedzwiedz W., Simpson L.J., Ohzeki M., Takata M., Sale J.E., and Patel K.J. Deubiquitination of FANCD2 is required for DNA crosslink repair (USP1). Mol. Cell 28 (2007) 798-809
95. Hanada K., Buzowska M., Modesti M., Maas A., Wyman C., Essers J., and Kanaar R. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 25 (2006) 4921-4932
96. Kuraoka I., Kobertz W.R., Ariza R.R., Biggerstaff M., Eismann J.M., and Wood R.D. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 275 (2000) 26632-26636
97. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., and Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15 (2004) 607-620
98. Takata M., Sasaki M.S., Tachiiri S., Fukushima T., Sonoda E., Schild D., Thompson L.H., and Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell Biol. 21 (2001) 2858-2866